Download presentation
Presentation is loading. Please wait.
Published byPaulina Freeman Modified over 6 years ago
1
Statin use and lower extremity amputation risk in nonelderly diabetic patients
Min-Woong Sohn, PhD, Judith L. Meadows, MD, Elissa H. Oh, MA, Elly Budiman-Mak, MD, MPH, Todd A. Lee, PharmD, PhD, Neil J. Stone, MD, William B. Pearce, MD Journal of Vascular Surgery Volume 58, Issue 6, Pages e1 (December 2013) DOI: /j.jvs Copyright © Terms and Conditions
2
Fig 1 Kaplan-Meier survival curves for (A) lower extremity amputation (LEA) and (B) treatment failure. This figure shows Kaplan-Meier survival curves for three treatment groups (None, Statin, and Other) over 5 years of follow-up for LEA and treatment failure. None, No cholesterol-lowering medications; Other, cholesterol-lowering medications other than statins; SE, standard error; Statin, statins alone. Journal of Vascular Surgery , e1DOI: ( /j.jvs ) Copyright © Terms and Conditions
3
Fig 2 Cumulative incidence function curves for lower extremity amputation (LEA) after adjusting for competing risks. This figure shows cumulative incidence function curves for three treatment groups (None, Statin, and Other) over 5 years of follow-up for LEA, adjusting for death as a competing risk. None, No cholesterol-lowering medications; Other, cholesterol-lowering medications other than statins; Statin, statins alone. Journal of Vascular Surgery , e1DOI: ( /j.jvs ) Copyright © Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.